Matthew D. Krueger

Partner

Matt Krueger is a former U.S. Attorney and partner in the firm’s Government Enforcement Defense & Investigations practice. He helps companies and individuals navigate government enforcement and complex litigation challenges, including False Claims Act and white collar matters. Matt also assists companies in mitigating risk by advising on compliance programs and conducting sensitive internal investigations, working with clients in a range of industries, with a focus on the health care sector, cybersecurity, and data privacy matters.

Government Enforcement Defense and Investigations

Matt helps clients facing allegations of misconduct, conducting internal investigations, persuading the government not pursue charges, and, when necessary, mounting a forceful defense. Before joining Foley, Matt served as the U.S. Attorney for the Eastern District of Wisconsin after being recommended by a bipartisan nominating commission. Under his leadership, the office successfully prosecuted high-profile cases involving national security, cybercrime, public corruption, health care fraud, securities fraud, and other offenses. Matt also served as an Assistant U.S. Attorney and the Health Care Fraud Coordinator in both the civil and criminal divisions, specializing in False Claims Act and white-collar matters.

Complex Litigation and Appeals

Matt offers first-chair trial and appellate counsel for clients facing high-stakes disputes. Before leading trials and appeals in the U.S. Attorney’s Office, Matt practiced trial and appellate litigation at an elite Washington, D.C. law firm. Matt also served as a Bristow Fellow in the Solicitor General’s Office, helping represent the United States before the Supreme Court. Matt now leads complex litigation matters, devising creative strategies to win cases.

Health Care and Life Sciences

Matt defends health care and life sciences companies in government investigation and enforcement actions, conducts sensitive internal investigations, and leads high-stakes litigation matters. As a federal prosecutor and in private practice, Matt has handled civil and criminal health care cases on a range of issues and clients, including matters involving the False Claims Act, Stark Law, the Anti-Kickback Statute, the Controlled Substances Act, medical device makers, hospitals and physician groups, pharmacies, skilled nursing facilities, and laboratories.

Cybersecurity and Data Privacy

Drawing on experience leading cybercrime prosecutions, Matt works closely with Foley’s cybersecurity and data privacy lawyers to investigate data incidents, respond to government inquiries, and litigate data privacy and security matters. Matt’s background also allows him to counsel clients on interacting with law enforcement and regulators to minimize risks.

As a former U.S. Attorney and Assistant U.S. Attorney, Matt Krueger has first chaired and supervised numerous federal jury trials. As a federal prosecutor, Matt focused on white-collar crime. He handled and supervised complex trials involving a broad range of financial matters, including tax fraud, wire fraud, money laundering, health care fraud, and other government program fraud. Matt’s approach is to develop clear trial themes and intuitive storytelling that allow jurors and judges to easily grasp complicated issues. He puts particular emphasis on ensuring that his client’s expert witness testimony augments the trial themes, while developing sharp cross-examinations of opposing experts that cut to the heart of the case. He also focuses on creating powerful demonstratives that engage jurors and convey the client’s story effectively. In this age of limited attention spans, Matt knows how to streamline a trial presentation and win.

Representative Experience

Government Enforcement Defense and Investigations

  • Advised a publicly traded manufacturer in managing a crisis arising from a vendor’s illegal employment practices. Minimized risk by cooperating with law enforcement, unwinding the vendor agreement, and briefing the board.
  • Defended the City of Milwaukee against a False Claims Act suit concerning the City’s administration of federal housing grants, winning complete dismissal of suit.
  • Led a review of a publicly traded manufacturer’s corporate compliance program, conducted a risk assessment, and recommended continuous improvement steps.
  • Represented an individual in responding to a federal grand jury investigation concerning financial fraud, resulting in no charges against the client.
  • Represented a manufacturer in responding to claims by the U.S. Department of Energy that its products did not meet energy conservation standards and negotiated a favorable settlement.

Complex Litigation and Appeals

  • Defended a leading children’s hospital in federal court against a civil rights suit, leading to a favorable settlement.
  • Defended a major health care system against a municipality’s suit that asserted claims related to opioid-dispensing practices. Obtained dismissal of entire suit.
  • Led the prosecution of a US$260m scheme to defraud federal contracting programs, resulting in the conviction of a corporation and six individuals, including a CPA after trial, as well as False Claims Act recoveries.
  • As United States Attorney, personally briefed and argued a rare interlocutory appeal before the Seventh Circuit, challenging the district court’s exclusion of evidence before trial. Obtained reversal and remand.
  • Led the prosecution of a US$9m green energy investment fraud whose victims included Chinese EB-5 visa applicants, a Canadian private equity fund and the State of Wisconsin, in coordination with the SEC’s parallel civil investigation.

Health Care and Life Sciences

  • Led an internal investigation for a health care system concerning allegations of misconduct by physicians.
  • Represented a genetic testing laboratory in responding to a federal grand jury investigation.
  • Obtained dismissal of citations and favorable settlement of civil monetary penalties assessed by HHS against a skilled nursing facility.
  • Led a False Claims Act investigation and settlement with an academic medical center related to claims for teaching physicians’ surgeries performed by residents without adequate supervision.
  • Led a False Claims Act investigation and litigation related to a health care system’s physician compensation for violating the Stark Law, resulting in a favorable settlement.

Cybersecurity and Data Privacy

  • Led an internal investigation for a financial services company regarding a data privacy incident. Determined grounds to avoid regulatory exposure and remedial steps to avoid the issue recurring.
  • Advised a manufacturing company in responding to a ransomware attack, including ways to maintain attorney-client privilege over the investigation and interact with law enforcement.
  • Serve as counsel to a trade association’s cybersecurity committee.

Clerkship and Other Experience

  • Bristow Fellow, Office of the Solicitor General, U.S. Department of Justice
  • Law clerk, Honorable Paul V. Niemeyer, U.S. Court of Appeals for the Fourth Circuit

Certification

  • Certified Information Privacy Professional/United States (CIPP/US), a key industry benchmark administered by the International Association of Privacy Professionals (IAPP)

Affiliations

  • Thomas E. Fairchild American Inn of Courts
  • Eastern District of Wisconsin Bar Association
  • American Health Law Association
  • International Association of Privacy Professionals
  • National Association of Former U.S. Attorneys

Presentations and Publications

  • Quoted, “Updated DOJ Compliance Guidance Adds AI; ‘If You’re Not Doing These Things, Why Not?’,” Law360 (September 30, 2024)
  • Quoted, “DOJ Offers Rewards for Tips About Corporate Fraud Against Private Payers,” Report on Medicare Compliance Volume 33, Number 28. (August 05, 2024)
  • Featured, “DOJ Criminal Division Extends Self-Disclosure Benefits to Individuals,” Report on Medicare Compliance Volume 33, Number 15 (April 22, 2024)
  • Co-author, “Implications of DOJ’s New Safe Harbor for Disclosing Misconduct Uncovered During M&A Transactions (October 10, 2023)
  • Quoted, “FCA Recoveries Drop; Lawyers See Other Data as More Significant,” Report on Medicare Compliance, Volume 32, Number 6 (February 13, 2023)
  • Quoted, “DOJ Certification Raises CCO ‘Risk Profile’; Consider ‘Your Own Due Diligence Checklist’,” Report on Medicare Compliance, Volume 31, Number 6 (July 25, 2022)
  • Co-author, “Maintaining Privilege of Forensic Reports,” Bloomberg Law (Sept. 23, 2021)
  • Presenter, “Health Care Fraud Enforcement Trends: New or Different Challenges Ahead?,” American Health Law Association In-House Counsel Program (June 17, 2021)
  • Panelist, “Hot Trends in DOJ and SEC Enforcement and Litigation 2021,” Sandpiper Partners LLC, Webinar (2021)
19 December 2024 In the News

Key Rulings On Sentencing Guidelines After Loper Bright

The U.S. Sentencing Guidelines are instrumental in criminal sentencing, as they provide courts with advisory ranges for imposing sentences.
23 January 2025 Events

7th Annual Let's Talk Compliance Conference

Start the new year with Foley & Lardner and PYA at the seventh annual Let's Talk Compliance virtual conference.
09 October 2024 Manufacturing Industry Advisor

What Every Multinational Company Should Know about … Conducting International Internal Investigations

Conducting effective cross-border internal investigations is more critical than ever for companies facing increasingly complex regulatory frameworks across the globe.
03 October 2024 Deals and Wins

Foley Secures Precedent-Setting Victory in Constitutional Challenge to the False Claims Act’s Qui Tam Provisions

Foley & Lardner LLP is pleased to announce a landmark victory in a constitutional challenge to the qui tam provisions of the False Claims Act, resulting in the dismissal of a lawsuit against its clients, Florida Medical Associates, LLC, et al.
30 September 2024 In the News

Matthew Krueger on Updated DOJ Compliance Guidance - 'Think about how to right-size it'

Foley & Lardner LLP partner Matthew Krueger commented on the U.S. Department of Justice's latest update to guidance on effective compliance programs in the Report on Medicare Compliance article, "Updated DOJ Compliance Guidance Adds AI; ‘If You’re Not Doing These Things, Why Not?’"
26 September 2024 Foley Viewpoints

DOJ Stresses AI Risk and Whistleblower Protection in Revised Corporate Compliance Guidance

On Monday, September 23, DOJ’s Criminal Division announced updates to its guidance for evaluating corporate compliance programs.